Status:
UNKNOWN
El DORADO STUDY (Evaluation of Delivery of Oxygen on Renal, Arrhythmia and Delirium Outcomes Study)
Lead Sponsor:
National University Hospital, Singapore
Conditions:
AKI
Neurocognitive Disorders
Eligibility:
All Genders
21-80 years
Brief Summary
The study aims to develop a novel perioperative noninvasive delivery of oxygen (DO2) and hemodynamic index in the prediction of postoperative outcomes including post-operative acute kidney injury (POA...
Detailed Description
Postoperative acute kidney injury, AF and neurocognitive disorders (POAKI, POAF and PONCD) are common complications post cardiac surgery. Postoperative neurocognitive disorders occur in up to 73% of c...
Eligibility Criteria
Inclusion
- Undergoing elective cardiac surgery such as valve replacements or CABG
- Age above 21 years old
- Ability to provide informed consent
Exclusion
- Emergency cardiac cases
- Patients on IABP postoperatively
- Patients who decline to participate in this study
- Pregnant women
Key Trial Info
Start Date :
July 27 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04895384
Start Date
July 27 2021
End Date
December 1 2024
Last Update
July 27 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore
2
Singapore General Hospital
Singapore, Singapore